193 related articles for article (PubMed ID: 8164448)
1. Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy.
Sarasin FP; Schifferli JA
Kidney Int; 1994 Feb; 45(2):578-85. PubMed ID: 8164448
[TBL] [Abstract][Full Text] [Related]
2. Venous Thromboembolism in Primary Nephrotic Syndrome - Is the Risk High Enough to Justify Prophylactic Anticoagulation?
Rankin AJ; McQuarrie EP; Fox JG; Geddes CC; MacKinnon B;
Nephron; 2017; 135(1):39-45. PubMed ID: 27669572
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum.
Glassock RJ
J Am Soc Nephrol; 2007 Aug; 18(8):2221-5. PubMed ID: 17599972
[TBL] [Abstract][Full Text] [Related]
4. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.
Lee T; Biddle AK; Lionaki S; Derebail VK; Barbour SJ; Tannous S; Hladunewich MA; Hu Y; Poulton CJ; Mahoney SL; Charles Jennette J; Hogan SL; Falk RJ; Cattran DC; Reich HN; Nachman PH
Kidney Int; 2014 Jun; 85(6):1412-20. PubMed ID: 24336031
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications.
Kelddal S; Nykjær KM; Gregersen JW; Birn H
BMC Nephrol; 2019 Apr; 20(1):139. PubMed ID: 31023275
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management.
Singhal R; Brimble KS
Thromb Res; 2006; 118(3):397-407. PubMed ID: 15990160
[TBL] [Abstract][Full Text] [Related]
7. Thrombo-prevention in membranous nephropathy: a new tool for decision making?
Glassock RJ
Kidney Int; 2014 Jun; 85(6):1265-6. PubMed ID: 24875548
[TBL] [Abstract][Full Text] [Related]
8. Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted?
Bellomo R; Atkins RC
Nephron; 1993; 63(3):249-54. PubMed ID: 8446259
[No Abstract] [Full Text] [Related]
9. Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.
Zou H; Li Y; Xu G
BMC Nephrol; 2019 Dec; 20(1):442. PubMed ID: 31791286
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases.
Kelddal S; Hvas AM; Grove EL; Birn H
BMC Nephrol; 2022 Sep; 23(1):305. PubMed ID: 36064370
[TBL] [Abstract][Full Text] [Related]
11. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Anticoagulation in Adult Patients with Nephrotic Syndrome.
Gordon-Cappitelli J; Choi MJ
Clin J Am Soc Nephrol; 2020 Jan; 15(1):123-125. PubMed ID: 31575616
[No Abstract] [Full Text] [Related]
13. Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability.
Dupree LH; Reddy P
Ann Pharmacother; 2014 Dec; 48(12):1655-8. PubMed ID: 25169250
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
Hartono C; Chung M; Kuo SF; Seshan SV; Muthukumar T
J Nephrol; 2014 Feb; 27(1):103-6. PubMed ID: 24430762
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolism in nephrotic syndrome: controversies and uncertainties.
Parker K; Ragy O; Hamilton P; Thachil J; Kanigicherla D
Res Pract Thromb Haemost; 2023 Aug; 7(6):102162. PubMed ID: 37680313
[TBL] [Abstract][Full Text] [Related]
16. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of thromboembolic events in patients with nephrotic syndrome.
Pincus KJ; Hynicka LM
Ann Pharmacother; 2013 May; 47(5):725-34. PubMed ID: 23613095
[TBL] [Abstract][Full Text] [Related]
18. Secondary polycythemia associated with idiopathic membranous nephropathy.
Lim CS; Jung KH; Kim YS; Ahn C; Han JS; Kim S; Lee JS
Am J Nephrol; 2000; 20(4):344-6. PubMed ID: 10970991
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?
Zaffanello M; Brugnara M; Fanos V; Franchini M
Int Urol Nephrol; 2009; 41(3):713-6. PubMed ID: 18696250
[TBL] [Abstract][Full Text] [Related]
20. Hyperlipidemia and thrombotic complications in patients with membranous nephropathy.
Nickolas TL; Radhakrishnan J; Appel GB
Semin Nephrol; 2003 Jul; 23(4):406-11. PubMed ID: 12923730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
